Practical approach to managing metabolic bone disease of prematurity in the neonatal unit.

This document provides guidelines for the management of metabolic bone disease of prematurity (MBDP) in infants. It emphasizes the importance of regular screening and monitoring of electrolyte levels, parathyroid hormone (PTH), and vitamin D levels in at-risk infants. The document recommends individualized supplementation of calcium, phosphate, and vitamin D based on specific needs and calcium:phosphate ratios. It also highlights the need for collaboration with dietitians or pediatric endocrinologists in cases of persistent abnormal biochemistry or suspected alternative diagnoses. [Extracted from the article]